Security
Skye Bioscience, Inc. Common Stock · SKYE
SKYENASDAQCommon stockCurrentCIK 1516551Updated Oct 29, 2026
Name history
Emerald Bioscience, Inc. · through Jan 7, 2021Nemus Bioscience, Inc. · through Mar 14, 2019LOAD GUARD LOGISTICS, INC. · through Oct 30, 2014LOAD GUARD TRANSPORTATION, INC. · through Nov 7, 2012
SKYE price & chart
Loading TradingView…
NASDAQ:SKYE on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
PRER14A filing
PREM14A filing
SCHEDULE 13G - filed by TANG CAPITAL MANAGEMENT LLC regarding Skye Bioscience, Inc.
DEFA14A filing
Termination of a Material Definitive Agreement · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other Events
Items 1.02, 5.02, 8.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 41,324,289Source | 81,535,660Source | 11,033,795Source | 52,160,911Source | 87,261,531Source | 19,416,736Source | 64,793,240Source | 94,835,276Source | 28,313,633Source | 72,763,773Source | 11,940,411Source | 9,111,072Source |
| Property, Plant and Equipment, NetUSD | 1,033,965Source | 1,516,612Source | 32,939Source | 1,169,056Source | 45,772Source | 756,077Source | 1,304,148Source | 36,076Source | 898,930Source | 1,432,752Source | 43,276Source | 87,854Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 18,441,079Source | 67,412,614Source | 8,068,357Source | 23,838,244Source | 74,120,854Source | 8,149,015Source | 46,421,299Source | 83,342,907Source | 5,882,498Source | 68,415,741Source | — | — |
| Assets, CurrentUSD | 39,924,794Source | 79,808,229Source | 10,958,887Source | 50,582,518Source | 87,004,463Source | 18,566,969Source | 63,027,781Source | 94,570,087Source | 27,094,147Source | 70,827,247Source | 11,650,843Source | 8,943,718Source |
| Operating Lease, Right-of-Use AssetUSD | 311,620Source | 184,509Source | 33,660Source | 355,427Source | 202,987Source | 57,781Source | 407,401Source | 220,804Source | 266,646Source | 449,864Source | 237,983Source | 71,191Source |
| Other Assets, NoncurrentUSD | 53,910Source | 26,310Source | 8,309Source | 53,910Source | 8,309Source | 35,909Source | 53,910Source | 8,309Source | 53,910Source | 53,910Source | 8,309Source | 8,309Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 8,488,104Source | 5,732,285Source | 11,531,102Source | 8,484,202Source | 14,452,480Source | 10,404,932Source | 5,542,926Source | 15,951,883Source | 8,289,458Source | 4,612,049Source | 14,072,229Source | 12,119,126Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 30,989Source | 30,338Source | 35,144Source | 30,988Source | 28,068Source | 35,128Source | 30,975Source | 28,063Source | 33,379Source | 30,975Source | 12,349Source | 913,528Source |
| Retained Earnings (Accumulated Deficit)USD | -172,432,523Source | -121,203,193Source | -210,170,441Source | -159,677,863Source | -117,304,896Source | -199,383,847Source | -142,052,991Source | -109,402,080Source | -186,874,486Source | -130,949,672Source | -104,382,549Source | -66,737,765Source |
| Stockholders' Equity Attributable to ParentUSD | 32,836,185Source | 75,803,375Source | -497,307Source | 43,676,709Source | 72,809,051Source | 9,011,804Source | 59,250,314Source | 78,883,393Source | 20,024,175Source | 68,151,724Source | -2,131,818Source | -3,008,054Source |
| Additional Paid in Capital, Common StockUSD | 205,237,719Source | 196,976,230Source | 209,637,990Source | 203,323,584Source | 190,085,879Source | 208,360,523Source | 201,272,330Source | 188,257,410Source | 206,865,282Source | 199,070,421Source | 102,238,382Source | 62,816,183Source |
| Liabilities and EquityUSD | 41,324,289Source | 81,535,660Source | 11,033,795Source | 52,160,911Source | 87,261,531Source | 19,416,736Source | 64,793,240Source | 94,835,276Source | 28,313,633Source | 72,763,773Source | 11,940,411Source | 9,111,072Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 8,367,897Source | 5,624,223Source | 11,531,102Source | 8,311,708Source | 14,322,573Source | 10,404,932Source | 5,319,460Source | 15,800,930Source | 8,205,459Source | 4,338,887Source | 13,900,999Source | 12,119,126Source |
| Operating Lease, Liability, CurrentUSD | 201,638Source | 82,932Source | 35,696Source | 195,046Source | 79,165Source | 60,980Source | 188,645Source | 75,535Source | 189,647Source | 182,428Source | 72,038Source | 78,700Source |
| Accounts Payable, CurrentUSD | 2,825,005Source | 780,025Source | 4,278,419Source | 3,222,510Source | 1,079,493Source | 3,936,948Source | 1,713,832Source | 1,095,134Source | 2,033,431Source | — | — | 1,669,997Source |
| Operating Lease, Liability, NoncurrentUSD | 120,207Source | 108,062Source | 0Source | 172,494Source | 129,907Source | 0Source | 223,466Source | 150,953Source | 83,999Source | 273,162Source | 171,230Source | 0Source |
| Additional Financial Items | ||||||||||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 35,312,308Source | — | 10,064,141Source | — | — | 17,108,629Source | — | — | 25,737,221Source | — | — | — |
| Short-term InvestmentsUSD | 16,871,229Source | — | 1,995,784Source | 24,747,039Source | — | 8,959,614Source | 12,802,650Source | — | 19,854,723Source | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 172,886Source | 177,379Source | 723,352Source | 298,640Source | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 1,496,989Source | 2,201,909Source | 7,767,694Source | 8,317,480Source | 987,510Source | 629,032Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -8,557,917Source | -9,185,480Source | -43,062,529Source | -25,237,480Source | -13,952,178Source | -12,744,072Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 10,895,959Source | -12,808,962Source | -19,500,285Source | -245,615Source | 6,596,456Source | 5,214,395Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 0Source | 6,312Source | 6,312Source | 1,604,027Source | 12,550Source | 28,060Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -71,525Source | 0Source | 29,571Source | 83,562,181Source | 16,443,270Source | -208,794Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 2,266,517Source | -21,994,442Source | -62,533,243Source | 58,079,086Source | 9,087,548Source | -7,738,471Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 18,441,079Source | 76,492,816Source | 8,068,357Source | 23,838,244Source | 8,149,015Source | 46,421,299Source | 5,882,498Source | 68,415,741Source | 10,336,655Source | 1,249,107Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 2,199Source | 0Source | 0Source | 433,336Source | 198,352Source | 333,547Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 1,914,136Source | 1,921,617Source | 1,271,209Source | 2,033,109Source | 1,496,989Source | 2,201,909Source | 7,767,694Source | 8,317,480Source | 987,510Source | 608,199Source |
| Amortization of Debt Issuance CostsUSD | — | — | — | 3,063Source | — | — | — | — | — | 16,456Source | 9,063Source | 1,359Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | — | 0Source | 0Source | 599,006Source | 329,890Source | 489,595Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | 35,312,308Source | — | 10,064,141Source | — | 17,108,629Source | — | 25,737,221Source | — | — | — |
| DepreciationUSD | — | — | — | — | — | — | — | — | 540,135Source | 203,757Source | 124,251Source | 114,998Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | — | — | — | 0Source | 45,350Source | -3,352Source |
| Gain (Loss) on Disposition of BusinessUSD | — | — | 91,400Source | 72,837Source | 178,200Source | 89,363Source | — | 0Source | 360,750Source | 1,358,412Source | -307,086Source | — |
| Gain (Loss) on Disposition of Other AssetsUSD | — | — | — | — | — | — | -7,615Source | 0Source | 0Source | -10,794Source | 4,080Source | — |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | — | — | — | — | — | — | — | 4,234,717Source | 151,842Source | -6,205,310Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | — | -307,086Source | 0Source |
| General and Administrative ExpenseUSD | — | — | 3,907,090Source | 4,638,927Source | 3,869,371Source | 3,906,172Source | 4,738,686Source | 4,562,305Source | 15,801,686Source | 17,725,741Source | 7,852,340Source | 6,094,617Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 3,400Source | 3,400Source | 0Source | 2,000Source | 5,400Source | 10,071Source | 3,600Source | 6,741Source |
| Induced Conversion of Convertible Debt ExpenseUSD | — | — | — | 0Source | — | — | — | — | — | 0Source | 1,383,285Source | — |
| InterestExpenseNonoperatingUSD | — | — | 0Source | -90,766Source | 3,299Source | 0Source | 2,199Source | 1,452Source | 0Source | 749,308Source | — | — |
| Investment Income, InterestUSD | — | — | 418,474Source | 907,697Source | 103,208Source | 533,090Source | 169,615Source | 619,054Source | 1,883,903Source | 3,028,762Source | 99,974Source | 19,011Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -12,754,660Source | -3,898,297Source | -10,786,594Source | -17,624,872Source | -12,509,361Source | -11,103,319Source | -55,924,814Source | -26,567,123Source | -37,644,784Source | -19,481,602Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -12,754,660Source | -3,898,297Source | -10,786,594Source | -17,624,872Source | -12,509,361Source | -11,103,319Source | -55,924,814Source | -26,567,123Source | -37,644,784Source | -19,481,602Source |
| Nonoperating Income (Expense)USD | — | — | 509,874Source | 1,070,499Source | 278,109Source | 622,453Source | 165,005Source | 658,243Source | 2,244,151Source | 3,635,666Source | -2,906,011Source | -1,163,129Source |
| Operating ExpensesUSD | — | — | 13,264,534Source | 4,968,796Source | 11,061,303Source | 18,243,925Source | 12,674,366Source | 11,759,562Source | 58,163,565Source | 30,192,718Source | 34,735,173Source | 18,311,732Source |
| Other Nonoperating Income (Expense)USD | — | — | 0Source | -801Source | 0Source | 0Source | -2,411Source | 40,641Source | -502Source | -2,200Source | — | — |
| Payments of Financing CostsUSD | — | — | — | — | — | — | — | — | — | 0Source | 6,026Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | 0Source | 4,973,684Source | 0Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | 0Source | 5,618Source | — | 0Source |
| Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal | — | — | — | — | — | — | — | — | — | — | — | — |
| Gain (Loss) on Disposition of Assets | — | — | — | —Source | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | -13,264,534Source | -4,968,796Source | -11,061,303Source | -18,243,925Source | -12,674,366Source | -11,759,562Source | -58,163,565Source | -30,192,718Source | -34,735,173Source | -18,311,732Source |
| Other Nonoperating Income (Expense)USD | — | — | 0Source | -801Source | 0Source | 0Source | -2,411Source | 40,641Source | -502Source | -2,200Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -12,754,660Source | -3,898,297Source | -10,783,194Source | -17,621,472Source | -12,509,361Source | -11,101,319Source | -55,919,414Source | -26,557,052Source | -37,641,184Source | -19,474,861Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 3,400Source | 3,400Source | 0Source | 2,000Source | 5,400Source | 10,071Source | 3,600Source | 6,741Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -12,754,660Source | -3,898,297Source | -10,786,594Source | -17,624,872Source | -12,509,361Source | -11,103,319Source | -55,924,814Source | -26,567,123Source | -37,644,784Source | -19,481,602Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.32Source | -0.1Source | -0.27Source | -0.44Source | -0.32Source | -0.28Source | -1.41Source | -0.73Source | -5.37Source | -0.04Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.32Source | -0.1Source | -0.27Source | -0.44Source | -0.32Source | -0.28Source | -1.41Source | -0.73Source | -5.37Source | -0.04Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 39,665,927Source | 38,819,387Source | 39,694,243Source | 39,659,266Source | 39,681,465Source | 39,651,888Source | 39,662,664Source | 36,486,519Source | 7,006,038Source | 555,270,089Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 39,665,927Source | 38,819,387Source | 39,694,243Source | 39,659,266Source | 39,681,465Source | 39,651,888Source | 39,662,664Source | 36,486,519Source | 7,006,038Source | 555,270,089Source |
| Interest Expense (non-operating)USD | — | — | 0Source | -90,766Source | 3,299Source | 0Source | 2,199Source | 1,452Source | 0Source | 749,308Source | — | — |
| Additional Financial Items | ||||||||||||
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 5,400Source | 10,071Source | 3,600Source | 6,741Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | — | — | — | 0Source | 45,350Source | -3,352Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | — | — | — | — | — | — | — | 4,234,717Source | 151,842Source | -6,205,310Source |
| General and Administrative ExpenseUSD | — | — | 3,907,090Source | 4,638,927Source | 3,869,371Source | 3,906,172Source | 4,738,686Source | 4,562,305Source | 15,801,686Source | 17,725,741Source | 7,852,340Source | 6,094,617Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -56,242,571Source | -27,495,672Source | -25,799,330Source | -18,801,570Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | 0Source | 749,308Source | 906,270Source | 665,133Source |
| Interest Expense, DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Investment Income, InterestUSD | — | — | 418,474Source | 907,697Source | 103,208Source | 533,090Source | 169,615Source | 619,054Source | 1,883,903Source | 3,028,762Source | 99,974Source | 19,011Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -12,754,660Source | -3,898,297Source | -10,786,594Source | -17,624,872Source | -12,509,361Source | -11,103,319Source | -55,924,814Source | -26,567,123Source | -37,644,784Source | -19,481,602Source |
| Nonoperating Income (Expense)USD | — | — | 509,874Source | 1,070,499Source | 278,109Source | 622,453Source | 165,005Source | 658,243Source | 2,244,151Source | 3,635,666Source | -2,906,011Source | -1,163,129Source |
| Operating ExpensesUSD | — | — | 13,264,534Source | 4,968,796Source | 11,061,303Source | 18,243,925Source | 12,674,366Source | 11,759,562Source | 58,163,565Source | 30,192,718Source | 34,735,173Source | 18,311,732Source |
| Research and Development ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 6,011,805Source |
Filing attachments
ex99_1.htm · SCHEDULE 13G · 2026-10-14
Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, par value $0.001, of Skye Bioscience, Inc. and further agree to the filing of this agreement as an exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file…
Read attachment ↗